Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

University of Pittsburgh Cancer Institute, Pittsburgh

Pennsylvania Oncology Hematology Association, Philadelphia

Institute for Drug Development Cancer Therapy and Research Center, San Antonio

Century City Hospital, Los Angeles